Abbreviations: BMI, body mass index; IQR, interquartile range; SCFT, subcutaneous fat thickness; SCN/ICN, special care nursery/Intensive care nursery. 
| INTRODUC TI ON
Obesity in pregnancy is associated with a range of adverse maternal and neonatal outcomes, including instrumental and cesarean delivery, gestational diabetes, preeclampsia, venous thromboembolism and fetal macrosomia. [1] [2] [3] Early pregnancy body mass index (BMI) is currently used to measure maternal obesity. 4 BMI does not measure the degree of abdominal obesity, which is known to be associated with metabolic risk in non-pregnant populations. 5, 6 The significance of abdominal obesity in pregnancy is unknown. It would be useful for patients and health professionals to be able to have a more accurate predictor of obesity-related pregnancy outcomes than BMI.
Data from the Framingham Heart Study demonstrated that both visceral and subcutaneous fat volume are associated with an increased risk of metabolic syndrome, with visceral fat showing a stronger relation. 6 Greater maternal abdominal subcutaneous fat thickness has been shown to correlate with higher serum levels of hemoglobin A1C and C reactive protein in pregnant women. 7 Recently, the utility of maternal abdominal subcutaneous fat thickness (SCFT)
as a measure of abdominal obesity in pregnancy and as a predictor of pregnancy outcomes has been explored. 8, 9 Suresh et al 8 retrospectively studied 1200 nulliparous women and found an ultrasound measurement of abdominal SCFT was better than BMI at predicting gestational diabetes, cesarean delivery and large-for-gestational-age neonates. Authors of that group subsequently prospectively studied 1385 women and concluded that SCFT was a significant independent predictor of adverse pregnancy outcomes. 9 These are the only published studies evaluating the relation between maternal abdominal SCFT and maternal and fetal outcomes.
This study aimed to determine whether maternal abdominal SCFT measured at the routine 18-to 20-week ultrasound is associated with adverse maternal and neonatal outcomes and whether it is a better predictor of those outcomes than the BMI measured at the booking-in appointment.
| MATERIAL AND ME THODS
This prospective cohort study was undertaken at a single tertiary Women's Hospital. Due to late referrals of women from regional centers, cases were included if they had ultrasound images obtained at more than 18 weeks' gestation or less than 23.9 weeks' gestation if these were for the purposes of the routine fetal anomaly scan. All images were obtained using a GE Voluson E8 machine (GE Healthcare, http://www3.gehealthcare.com.au/en-AU) with a curvilinear ultrasound probe (C1-5, C-4-8 RAB). The abdominal SCFT measurements were taken at the cervix-placenta view ( Figure 1 ).
This was obtained by placing a standard convex array ultrasound transducer, mid-sagittal and superior to the symphysis pubis, measuring in the midline through the linea alba. Landmarks demonstrated on the ultrasound image were the bladder, cervix and uterus.
The image contained the skin line and the subcutaneous tissue layer in the near field. These landmarks ensured that the image and subcutaneous fat measurements were reproducible. The first measurement was made in the midline and two measurements were taken on either side 5 mm apart. The measurements were done perpendicular to the anterior border. The caliper was placed from the skin line to the peritoneal fascia. Sonographers were encouraged to obtain the best view for their clinical purpose -in very obese women this would usually involve lifting the pannus; however, this was not dictated. The ultrasounds were performed by sonographers trained in obstetric ultrasound scanning; subsequently one trained operator reviewed the three measurements, which were averaged to give the SCFT for all participants. On some images the calipers measured in pixels rather than mm, in which case the measurement was adjusted to millimeters using a conversion factor.
Key message
Maternal abdominal subcutaneous fat thickness can be measured using ultrasound and is a measure of abdominal obesity. Subcutaneous fat thickness is correlated with body mass index in pregnancy and both predict mode of delivery. Body mass index remains the most clinically useful for now. 
| Statistical analyses
This was a sample of convenience, collected over a 17-month period, with the aim of collecting 1000 maternal-neonatal pairs. A post-hoc calculation determined that a sample size of 1000 has at least an 80% power to detect an odds ratio ( Sensitivity analyses were performed to investigate the validity and robustness of the adjustment factors in the models.
The study population was compared with the remainder of the women delivering singletons of a viable age (≥ 24 weeks' gestation) at the same institution during the study period. The maternal age, parity, gestation at delivery and mode of delivery of these two groups were compared using Chi-square test or an independent sample t test to identify potential bias within our sample.
Statistical analyses were considered significant at the 5% significance level and all analyses were performed in SPSS Version 22
(SPSS Inc., Chicago, IL, USA). 
| Ethical approval

| RE SULTS
Data were collected between February 2015 and June 2016.
During this time there were 6034 total singleton deliveries and our final sample included 997 women. Figure 2 is a flowchart of the cohort. Two neonatal deaths of pre-viable gestational age were excluded. Only women who had an appropriate ultrasound image, appropriate height and weight data, who delivered in our institution and did not opt-out of the research, were included in the final sample. Unadjusted and adjusted odds ratios from logistic regression models and coefficients from linear regression models for the primary outcome measure and secondary outcomes are shown in Table 2 . BMI and SCFT were both significantly associated with cesarean delivery, gestational diabetes, gestational hypertension/preeclampsia, neonatal hypoglycemia and birthweight.
SCFT was a marginally better predictor than BMI of the need for any newborn resuscitation and had a stronger positive association with Special care nursery/Intensive care nursery (SCN/ ICN) admission. All R 2 values were <0.17, explaining less than 17% of the variability in each of the maternal and neonatal outcomes. Neither BMI or SCFT was significantly associated with hemorrhage requiring transfusion or delivery prior to 37 weeks' gestation.
Of the 5037 women who delivered singletons during the study period at the same institution, 4999 delivered at ≥24 weeks' gestation. Table 3 shows a comparison of these 4999 women with the 997 included in the study sample based on maternal age, parity, gestation at delivery and mode of delivery.
| D ISCUSS I ON
This study confirmed that maternal abdominal SCFT obtained by ultrasound at the routine fetal anomaly ultrasound scan is significantly associated with cesarean delivery and performs as well as the BMI measured at the booking-in appointment in predicting this outcome.
When controlling for other contributory variables, maternal SCFT and BMI both showed a significant association with gestational hypertension/preeclampsia, gestational diabetes, neonatal hypoglycemia and birthweight. Maternal SCFT and BMI explained <17% of the variability observed in these outcomes. Maternal abdominal SCFT and BMI were highly correlated but had different associations with neonatal outcomes. SCFT, but not BMI, was associated with admission to SCN/ICN and the requirement for neonatal resuscitation. Although the number of events was small, the association between maternal SCFT (but not BMI) and 5-minute Apgar score was also significant. Conversely, although both BMI and SCFT were significantly associated with birthweight, the magnitude of that relation was greater for BMI.
This study builds on the limited published work that has examined the relation between maternal subcutaneous fat thickness and pregnancy outcomes. 8, 9 Other measures of abdominal adiposity include waist circumference, skin-fold thickness, computed tomography and, most recently, MRI and dual x-ray absorptiometry. 13 Not all of these are suitable for use in pregnancy. The attractiveness of maternal abdominal SCFT as a risk predictor is its incorporation into a preexisting and low-risk antenatal screening examination which is widely accepted by pregnant women. While this examination is recommended to occur between 18 and 22 weeks' gestation, we accepted ultrasound images that were taken at up to 23.9 weeks' gestation because of the referral patterns to our hospital. Similarly, the booking-in BMI, which would ideally be documented at 12-13 weeks' gestation, was frequently obtained later in pregnancy and we accepted data calculated on measurements at up to 23.9 weeks' gestation. This discrepancy is a limitation of this study, as these two antenatal variables may both vary throughout the gestational period.
We detected statistically significant differences between our study sample and the remainder of women delivering singletons of viable age at our institution during the study period. The groups were statistically different in terms of maternal age, parity, gestation at delivery and mode of delivery. The study sample had a lower proportion of cesarean deliveries and a higher proportion of women with a parity of one or greater. The observed differences in mode of delivery, age and gestation at delivery are small in clinical terms and will have little impact on the representativeness of our study sample.
The rates of obesity, 14 gestational diabetes 14 and gestational hypertension/preeclampsia 14, 15 in pregnancy in our sample were consistent with those quoted in the literature concerning Australian pregnant women. Our sample included 30% non-Caucasian women, which is higher than the 5% in the paper by Kennedy et al. 9 It is known that the requirement for written informed consent in observational studies can lead to selection bias. 16 We believe the use of an opt-out approach in this study facilitated our recruitment of a sample with greater ethnic diversity. This is important given that TA B L E 1 Univariate analysis for the association of body mass index (BMI) and maternal subcutaneous fat thickness (SCFT) with maternal demographic characteristics, comorbidities and maternal and neonatal outcome variables, n = 997. Analysis done on log-transformed data and back-transformed for interpretation pregnancy outcomes such as preeclampsia 17 and gestational diabe- ICN admission) that were not included in previous publications. 8, 9 Our sample size was large, at 997, but one of convenience, undertaken during a period when obtaining the appropriate ultrasound scan images and measurements was possible. The lack of an a priori sample size calculation is a limitation of our study. A constraint of using an opt-out approach, is that the final sample is not identified until all the opt-out declarations (written and electronic) have been received.
Although our study was undertaken prospectively, the maternal abdominal SCFT measurements were obtained after the USS had been completed for clinical purposes. Several ultrasound operators performed the ultrasound scans according to a prescribed protocol, potentially increasing inter-observer variation. However, a single trained operator was able to assess and derive all the maternal abdominal SCFT measurements.
When obtaining the cervix-placenta view in obese pregnant women, the method of obtaining the optimum probe position is variable. Lifting the pannus to obtain the cervical-placenta view would result in a reduced SCFT, and scanning through the pannus would increase the SCFT measurement obtained. Ultrasonographers were encouraged to obtain the best practical view for the clinical ultrasound, which would usually require lifting the pannus. The degree of tissue compression required to obtain the "best image" is also operator-dependent and may have introduced variability into these results.
The effect sizes are presented in Table 2 The method of recruitment can also influence the selection bias in the final sample. The current study included more non-Caucasian women than in the study by Kennedy et al. 9 An assessment of maternal abdominal SCFT in different ethnic populations may identify the degree to which ethnicity affects the association between maternal abdominal SCFT and pregnancy outcomes.
| CON CLUS ION
The use of ultrasound-measured maternal abdominal SCFT as a predictor of risk in pregnancy is attractive due to its convenience, low cost and acceptability to women. However, as an accurate predictor of pregnancy risk, maternal abdominal SCFT requires further evaluation. There is now consistent evidence to show a correlation between maternal SCFT and BMI in pregnancy, but there is no conclusive evidence to identify abdominal SCFT as superior to BMI when predicting maternal outcomes. Both explain <17% of the variability of the outcomes considered here. There is inadequate information to recommend its use clinically at present. It is important to keep searching for an accurate measure of obesity and risk in pregnancy, that is, one that is as practical and acceptable as maternal abdominal SCFT and BMI. In the meantime, BMI remains the clinical tool of choice.
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